2003
DOI: 10.1056/nejmoa021986
|View full text |Cite
|
Sign up to set email alerts
|

Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

21
437
11
18

Year Published

2004
2004
2013
2013

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 620 publications
(487 citation statements)
references
References 26 publications
(27 reference statements)
21
437
11
18
Order By: Relevance
“…This question must be viewed in relation to the magnitude of genetic effects under study. Given a substantial magnitude of effect and a highly significant P value, only a few dozen markers probably need to be genotyped to rule out gross stratification as an explanation for the positive association 11,22 (Table 3). In contrast, if the results point to more modest influences on disease, such as the risk due to variation in CTLA4 on autoimmune thyroid disease and type 1 diabetes 23 , it may be necessary to genotype a larger number of markers to rule out modest amounts of stratification.…”
Section: Figurementioning
confidence: 99%
“…This question must be viewed in relation to the magnitude of genetic effects under study. Given a substantial magnitude of effect and a highly significant P value, only a few dozen markers probably need to be genotyped to rule out gross stratification as an explanation for the positive association 11,22 (Table 3). In contrast, if the results point to more modest influences on disease, such as the risk due to variation in CTLA4 on autoimmune thyroid disease and type 1 diabetes 23 , it may be necessary to genotype a larger number of markers to rule out modest amounts of stratification.…”
Section: Figurementioning
confidence: 99%
“…Refractory epilepsy is a common neurologic disease that accounts for approximately one-third of epileptic patients with resistance to single or multiple drugs used for antiepileptic treatment [1,2] . Clinical studies have shown that if the first antiepileptic drug (AED) prescribed was ineffective, switching to another AED or to a combination of AEDs yielded similar negative results.…”
Section: Introductionmentioning
confidence: 99%
“…[6][7][8] However, most candidate gene association studies on AED resistance have focused on an individual genetic variant with the potential main effect, and none of these studies could find evidence for a strong, single-gene effect on AED resistance. [9][10][11][12] This is partially because of the limitations of parametric statistical methods for detecting gene effects that are solely or partially dependent on interactions with other genes. 13,14 In this study, with the working hypothesis that AED resistance is a polygenic disorder in which several genetic variants with a modest effect interact with each other, we tried to find pharmacogenetic evidence of epistatic interactions underlying AED resistance using a new statistical method.…”
Section: Introductionmentioning
confidence: 99%